The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
CONCLUSIONS: Universal tumour testing strategies for guiding germline genetic testing of people with incident CRC for LS in Australia are likely to be cost-effective compared with no testing. Universal germline gene panel testing would not currently be cost-effective.
PMID: 31595523 [PubMed - as supplied by publisher]
Source: Medical Journal of Australia - Category: General Medicine Tags: Med J Aust Source Type: research
More News: Australia Health | Cancer | Cancer & Oncology | Colonoscopy | Colorectal Cancer | Gastroschisis Repair | General Medicine | Genetics | HNPCC | Lynch Syndrome